AUTL

2.61

7.41% 0.18

Handel nachbörslich: 2.60 -0.010 -0.38%

Autolus Therapeutics Plc Adr (AUTL)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$2.43

Offen:

$2.45

24-Stunden-Volumen:

1.35M

Relative Volume:

0.64

Marktkapitalisierung:

$694.63M

Einnahmen:

Nettoeinkommen (Verlust:

$-208.38M

KGV:

-2.175

EPS:

-1.2

Netto-Cashflow:

$-156.57M

1W Leistung:

+4.82%

1M Leistung:

+27.32%

6M Leistung:

+20.83%

1J Leistung:

-39.30%

1-Tages-Spanne:

$2.41

$2.61

1-Wochen-Bereich:

$2.39

$2.61

52-Wochen-Spanne:

$1.105

$5.00

Autolus Therapeutics Plc Adr Stock (AUTL) Company Profile

Firmenname

Autolus Therapeutics Plc Adr

Sektor

Healthcare (1161)

Branche

Biotechnology (653)

Telefon

44 20 3829 6230

Adresse

THE MEDIAWORKS, LONDON

Mitarbeiter

647

Twitter

Nächster Verdiensttermin

2024-12-12

Neueste SEC-Einreichungen

AUTL's Discussions on Twitter

Vergleichen Sie AUTL mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
AUTL Autolus Therapeutics Plc Adr	2.61	662.68M	0	-208.38M	-156.57M	-1.20
VRTX Vertex Pharmaceuticals Inc	470.13	119.21B	11.10B	-988.90M	-1.26B	-3.92
REGN Regeneron Pharmaceuticals Inc	560.93	59.16B	14.09B	4.50B	2.96B	39.28
ALNY Alnylam Pharmaceuticals Inc	325.28	40.57B	2.35B	-269.70M	-75.39M	-2.09
ARGX Argen X Se Adr	571.23	34.02B	2.58B	1.06B	-1.28B	16.33
ONC Beone Medicines Ltd Adr	295.59	29.19B	3.81B	-644.79M	-669.77M	-6.24

Autolus Therapeutics Plc Adr Stock (AUTL) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-11-18	Hochstufung	Goldman	Neutral → Buy
2024-11-15	Hochstufung	Redburn Atlantic	Neutral → Buy
2023-11-09	Eingeleitet	Deutsche Bank	Buy
2023-03-27	Fortgesetzt	Wells Fargo	Overweight
2023-03-17	Eingeleitet	Bryan Garnier	Buy
2021-06-14	Hochstufung	Jefferies	Hold → Buy
2021-01-29	Herabstufung	JP Morgan	Overweight → Neutral
2020-12-28	Fortgesetzt	H.C. Wainwright	Buy
2020-07-31	Eingeleitet	JP Morgan	Overweight
2020-07-22	Eingeleitet	SunTrust	Buy
2020-04-22	Eingeleitet	Mizuho	Buy
2019-09-23	Eingeleitet	Needham	Buy
2019-05-17	Bestätigt	H.C. Wainwright	Buy
2018-10-24	Eingeleitet	H.C. Wainwright	Buy

Alle ansehen

Autolus Therapeutics Plc Adr Aktie (AUTL) Neueste Nachrichten

Jul 22, 2025

Autolus Therapeutics’ (AUTL) Buy Rating Reaffirmed at Needham & Company LLC - Defense World

Jul 22, 2025

Jul 21, 2025

European Commission approves Autolus’ cell therapy for adult leukemia - Investing.com India

Jul 21, 2025

Autolus Therapeutics’ CAR T Therapy AUCATZYL® (Obecabtagene Autoleucel) Granted European Marketing Authorization for Adult Patients (age 26 and older) with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (R/R B-ALL) - GlobeNewswire Inc.

Jul 21, 2025

Jul 09, 2025

Cambridge Investment Research Advisors Inc. Sells 2,160 Shares of Invesco KBW Property & Casualty Insurance ETF (NASDAQ:KBWP) - Defense World

Jul 09, 2025

Allspring Global Investments Holdings LLC Sells 439,622 Shares of Dr. Reddy’s Laboratories Ltd (NYSE:RDY) - Defense World

Jul 09, 2025

1,867 Shares in Axsome Therapeutics, Inc. (NASDAQ:AXSM) Bought by DAVENPORT & Co LLC - Defense World

Jul 09, 2025

DAVENPORT & Co LLC Trims Holdings in Janus Henderson Short Duration Income ETF (NYSEARCA:VNLA) - Defense World

Jul 09, 2025

Vontobel Holding Ltd. Lowers Holdings in Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL) - Defense World

Jul 09, 2025

Allspring Global Investments Holdings LLC Raises Holdings in Broadstone Net Lease, Inc. (NYSE:BNL) - Defense World

Jul 09, 2025

Wealth Enhancement Advisory Services LLC Takes $258,000 Position in Taylor Morrison Home Corporation (NYSE:TMHC) - Defense World

Jul 09, 2025

TELUS International (Cda) (TSE:TIXT) Trading 2.1% Higher – What’s Next? - Defense World

Jul 09, 2025

Jun 17, 2025

Closing Figures: Autolus Therapeutics plc ADR (AUTL)’s Negative Finish at 2.05, Down -3.30 - DWinneX

Jun 17, 2025

Jun 12, 2025

NOV Inc: Navigating Market Volatility with a 1.79 Debt-to-Equity Ratio - investchronicle.com

Jun 12, 2025

Jun 05, 2025

Autolus shares surge 77% following InvestingPro’s April Fair Value signal By Investing.com - Investing.com India

Jun 05, 2025

May 23, 2025

EMA committee endorses Autolus’ leukemia therapy obe-cel By Investing.com - Investing.com South Africa

May 23, 2025

Autolus Therapeutics Gets Favorable Recommendation For Approval Of Cancer Therapy In EU: Retail Sentiment Brightens By Stocktwits - Investing.com India

May 23, 2025

EMA committee endorses Autolus’ leukemia therapy obe-cel - Investing.com

May 23, 2025

May 16, 2025